Roberto N Miranda Selected Research

Roberto N Miranda Research Topics

Disease

46	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2022 - 04/2012
37	Neoplasms (Cancer) 10/2022 - 10/2004
28	Lymphoma (Lymphomas) 06/2022 - 08/2011
19	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 07/2012
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2017 - 01/2011
8	Disease Progression 01/2022 - 01/2013
7	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018 - 03/2010
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2022 - 06/2013
4	B-Cell Lymphoma (Lymphoma, B Cell) 12/2021 - 11/2012
4	Blast Crisis (Blast Phase) 01/2020 - 03/2011
4	Seroma 01/2020 - 01/2017
3	Fibrosis (Cirrhosis) 10/2021 - 10/2003
3	Eosinophilia 01/2021 - 09/2015
3	Inflammation (Inflammations) 01/2020 - 05/2005
3	Chromosome Aberrations (Chromosome Abnormalities) 12/2017 - 04/2010
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2017 - 03/2011
3	Large Granular Lymphocytic Leukemia 01/2017 - 10/2015
3	Infections 12/2016 - 12/2006
2	Hypoxia (Hypoxemia) 01/2021 - 10/2017
2	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 01/2019
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 09/2020 - 05/2016
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 08/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 02/2017
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 08/2011
2	Mycosis Fungoides 01/2018 - 01/2016
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 02/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2016 - 03/2011
2	Thrombocytopenia (Thrombopenia) 11/2015 - 12/2002
2	Lymphadenopathy 10/2015 - 03/2012
2	Genetic Translocation (Chromosomal Translocation) 12/2014 - 04/2010
2	Epstein-Barr Virus Infections 08/2014 - 08/2013
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 01/2022
1	Foreign Bodies (Foreign Body) 10/2021
1	Contracture 05/2021
1	Residual Neoplasm 01/2021
1	Rare Diseases (Rare Disease) 06/2020
1	Primary Effusion Lymphoma 04/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020
1	Burns 01/2020
1	Pdgfra-Associated Chronic Eosinophilic Leukemia 11/2018
1	Spontaneous Remission 01/2018
1	Hypersensitivity (Allergy) 01/2018

Drug/Important Bio-Agent (IBA)

10	Capsules (Microcapsules)IBA 12/2021 - 07/2012
8	Anaplastic Lymphoma KinaseIBA 06/2022 - 09/2009
7	Biological ProductsIBA 01/2020 - 03/2015
6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 07/2012
6	Rituximab (Mabthera)FDA Link 12/2015 - 01/2011
5	AntigensIBA 01/2022 - 06/2013
4	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2021 - 09/2015
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2013
4	CytokinesIBA 01/2020 - 12/2016
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 12/2012
3	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2021
3	Cyclin D1IBA 01/2022 - 04/2002
3	Phosphotransferases (Kinase)IBA 01/2021 - 10/2012
3	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 12/2012
3	Vincristine (Oncovin)FDA LinkGeneric 11/2015 - 01/2011
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2015 - 01/2011
2	SiliconesIBA 10/2021 - 12/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2012
2	Immunoglobulin M (IgM)IBA 09/2020 - 05/2016
2	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2015
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020 - 12/2012
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 08/2016
2	ibrutinibIBA 01/2020 - 02/2016
2	Interleukin-13IBA 01/2020 - 01/2018
2	Bortezomib (Velcade)FDA Link 10/2017 - 02/2016
2	Granzymes (Granzyme)IBA 02/2017 - 11/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2017 - 08/2013
2	Azathioprine (Imuran)FDA LinkGeneric 02/2017 - 08/2013
2	Methotrexate (Mexate)FDA LinkGeneric 11/2015 - 08/2013
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2015 - 04/2010
2	Tyrosine (L-Tyrosine)FDA Link 12/2014 - 10/2012
2	Thalidomide (Thalomid)FDA Link 12/2014 - 08/2013
2	Prednisone (Sone)FDA LinkGeneric 11/2012 - 01/2011
2	Serine (L-Serine)FDA Link 10/2012 - 08/2011
1	AsbestosIBA 10/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2021
1	Interleukin-9 (Interleukin 9)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Interleukin-22 (IL-22)IBA 01/2020
1	ChemokinesIBA 01/2020
1	LigandsIBA 01/2020
1	InterferonsIBA 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	HLA-A Antigens (HLA-A)IBA 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 10/2017

Therapy/Procedure

44	Breast Implants (Breast Implant) 10/2022 - 09/2009
24	Therapeutics 12/2021 - 12/2002
9	Drug Therapy (Chemotherapy) 12/2016 - 03/2012
3	Splenectomy 01/2017 - 11/2012
1	Immunotherapy 01/2020
1	Organ Transplantation 01/2020
1	Mammaplasty (Breast Reconstruction) 01/2019
1	Induction Chemotherapy 12/2017